Tirzepatide (Mounjaro) · 10mg · Pen

Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist designed as a single synthetic peptide. It acts on both incretin receptors simultaneously, demonstrating superior glycaemic control and body weight reduction compared to GLP-1 mono-agonists in research models. Studied extensively in metabolic research, obesity biology, insulin sensitivity modulation, and pancreatic beta-cell function. This pre-filled pen format allows for precise, consistent research administration.

Synthesised and lyophilised in Zürich to >99% HPLC purity. Lot-traceable with full COA available upon request.

For research purposes only. Not for human consumption. Supplied in accordance with EU Regulation (EC) No 1907/2006 (REACH) for research and analytical use.